Gumampong, Baby Boy .
HRN: 22-39-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2023
AMPICILLIN 250MG (VIAL)
01/11/2023
01/18/2023
IV
90mg
Q12H
T/C Perinatal Asphyxia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes